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Abstract
Background
The Gambia’s National Eye Health Programme has made a concertedeffort to reduce the
prevalence of trachoma. The present study had two objectives. The first was to conduct sur-
veillance following mass drug administrations to determinewhether The Gambia has
reached theWorld Health Organization’s (WHO) criteria for trachoma elimination, namely a
prevalence of trachomatous inflammation—follicular (TF) of less than 5% in children aged 1
to 9 years. The second was to determine the prevalence of trichiasis (TT) cases unknown to
the programme and evaluate whether thesemeet theWHO criteria of less than 0.1% in the
total population.
Methodology/PrincipalFindings
Three cross-sectional surveys were conducted between 2011 and 2013 to determine the
prevalence of TF and TT in each of nine surveillance zones. Each zone was of similar size,
with a population of 60,000 to 90,000, once urban settlementswere excluded. Trachoma
grading was carried out according to theWHO’s simplified trachoma grading system. The
prevalence of TF in children aged 1 to 9 years was less than 5% in each surveillance zone
at each of the three surveys. The prevalence of TT cases varied by zone from 0 to 1.7% of
adults greater than 14 years while the prevalence of TT cases unknown to the country’s
National Eye Health Programmewas estimated at 0.15% total population.
Conclusions/Significance
The Gambia has reached the elimination threshold for TF in children. Furtherwork is
needed to bring the number of unknown TT cases below the elimination threshold.
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Author Summary
Trachoma, the world’s leading infectious cause of blindness, is caused by ocular infection
with the bacteriumChlamydia trachomatis. The Gambia, situated inWest Africa, has
implemented all facets of theWorld Health Organization-recommended SAFE strategy
for trachoma control including surgery to correct the in-turning of eyelashes (trichiasis),
mass drug administration with antibiotics, promotion of facial hygiene and environmental
improvements. In 2011, The Gambia’s National Eye Health Programme began three years
of rolling surveys to determine the prevalence of trachoma in the country and to evaluate
whether trachoma elimination has been reached. The results suggest the country has
reached the elimination threshold for trachoma in children (less than 5% prevalence) but
that more work needs to be done to reduce the prevalence of trichiasis in adults.
Introduction
Trachoma, caused by the obligate intracellular bacteriumChlamydia trachomatis, is believed to
be endemic in at least fifty countries, primarily in Africa and Asia [1]. The disease is character-
ized by repeated episodes of follicular conjunctivitis in childhood, resulting in progressive scar-
ring of the upper eyelid, in-turning of the eyelashes (trichiasis; TT) and corneal opacification in
later life [2]. Recognising that concerted action to control the disease was needed, theWorld
Health Organization (WHO), in 1996, proposed the ‘SAFE’ strategy of trachoma control: Sur-
gery to correct trichiasis,Antibiotics to treat ocular chlamydial infection, and the promotion of
Facial cleanliness and Environmental Improvement to address risk factors associated with the
transmission of the infection [3].
The Gambia, situated in the Sahel of West Africa, has done much to implement the SAFE
strategy to control trachoma within its borders. In 1986, following a national survey that deter-
mined trachoma was the second leading cause of blindness in the country [4], the National Eye
Health Programme (NEHP) was formed and a network of community ophthalmic nurses was
trained to screen communities for active trachoma and to conduct trichiasis surgery. Public
health initiatives with a focus on preventative eye care and facial cleanliness have been targeted
to school children and rural communities while urban centres have benefitted from a targeted
programme designed to meet the eye health needs of marginalised populations. In 2007, a
mass drug administration (MDA) programme, which distributedmore than 400,000 doses of
azithromycin, was rolled out in twenty-three priority health districts.Most recently, trichiasis
case-hunting and surgery camps have been carried out across the rural regions of the country.
In 1996, a second survey of blindness found the prevalence of active trachoma in children
aged 0 to 9 was approximately 7% nationally [5]. A decade later, population-based surveys con-
ducted in two regions in advance of the MDA campaign found greater than 10% prevalence of
trachomatous inflammation—follicular (TF) in the same age group [6]. Based on these data,
eleven rural districts with predicted prevalence greater than 10% were earmarked for three
rounds of MDA with azithromycin according to theWHO criteria. Treatment began in 2007
and finished in 2010. In another twelve districts where the prevalence of TF in children was
projected to be between 5 and 10%, a screen and treat strategy was adopted. Under this scheme,
community-based screening of all children aged 1 to 9 years was first carried out. If the preva-
lence of TF in 1 to 9 year olds was greater than 10%, the community was selected for three
rounds of MDA. If the prevalence was less than 10%, households of active cases were treated
with one round of MDA. In 2011, the Partnership for the Rapid Elimination of Trachoma, or
PRET study, surveyed four formerly endemic districts by conducting screening in villages that
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had received either one round of MDA three years previously or three rounds of MDA com-
pleted one year previously. The results demonstrated very low levels of TF and ocular chlamyd-
ial infection in all communities surveyed and suggested the countrymight have reached the
elimination benchmark of TF prevalence less than 5% in children [7].
TheWHO has convened global scientificmeetings on post-endemic surveillance for tra-
choma and these have established criteria for the elimination of trachoma as a public health
problem [8, 9]. These criteria indicate that, following three years of surveillance, countries
would be required to demonstrate, through appropriately powered surveys of rural areas, that
(i) the prevalence of TF among 1–9 year olds was less than 5% and (ii) that the prevalence of
‘unknown’ cases of trichiasis (those that have never been offered surgery) was less than one per
thousand (0.1%) of the total population in each district. A district was defined notionally as a
unit of 250,000 population.With this advice in mind, the NEHP conducted a rolling pro-
gramme of rural trachoma surveys over three years designed to show that TF prevalence
remained low and that elimination criteria had beenmet. TT prevalence was also assessed and
the results generated were used to calculate the number of TT cases unknown to the NEHP
throughout the country.
Methods
Study site
The regions of The Gambia were divided, on the basis of their population in the 2003 national
census, into nine zones (A-I; Fig 1). Gambian administrative districts are significantly smaller
than those in many other countries and the zones were constructed to be functionally equiva-
lent to ‘sub-districts’ by amalgamating multiple contiguous districts to give similar sized units
of 60,000–90,000 population. Urban settlements, as designated by The Gambia Statistics
Department [10], were excluded as per theWHO recommendations.
Sampling strategy
A sample size of 1,448 individuals for each population unit of 60,000 to 90,000 (zones A to I)
was deemed necessary to estimate a prevalence of TF, in children aged 1 to 9 years, of 3%
within a precision of +/- 2% given a 95% confidence limit and a design effect of 4. As sampling
was intended to proceed over 3 years, this equated to 483 individuals aged 1 to 9 to be exam-
ined per zone, per year. The average Gambian household was estimated to contain 9 people, of
whom 3.5 are in the age range 1–9; to achieve the required sample size, 138 households would
need to be screened in each zone, each year. We therefore chose to conservatively target 160
households annually in each of the surveillance zones. This was achieved by selecting 16 settle-
ments in each zone by probability proportional to size, conducting a census to list all house-
holds in each settlement and then screening ten randomly selected households from the list in
each settlement for ocular examinations. A further two households were randomly selected as
Fig 1. Map of TheGambia indicating the boundaries of the trachomasurveillance zones.
doi:10.1371/journal.pntd.0004906.g001
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reserve households in the case of selected households being unavailable or choosing not to par-
ticipate. In the case of large settlements (>1,000 population), segments of the village, defined
on the basis of landmarks by the national census data, were selected for screening.
Based on the 2011 and 2012 results, the sample size was doubled in 2013 in order to have
TF prevalence data in all zones from a single survey adequately powered to demonstrate that
TF was less than 5% in each zone and thus fulfil the criteria for elimination.
Data collection
Data collection took place from July 2011 to June 2013. Prior to the onset of field-work, a work-
shop was held for all community ophthalmic nurses and healthcare workers involved in the
surveys. Training included quality control exercises of trachoma grading from slides in a class-
room setting followed by practical exercises in the field. Graders were required to achieve
agreement (kappa coefficients of 0.8 or more) for TF with a senior grader (RB) for the slide
grading exercise, which consisted of a variety of images from The Gambia, Niger and Tanzania
and which were used in the validation system for the PRET study [7]. During the surveys, all
household members, defined as those who slept in the household the night before, were eligible
for screening. Consenting individuals were examined for clinical signs of trachoma using a
2.5× magnifying loupe and adequate sun or torch-light. Trachoma grading was carried out
according to theWHO simplified grading system [11]; TF was defined as the presence of five
or more follicles, greater than 0.5mm diameter, on the upper tarsal conjunctiva and TTwas
defined as at least one lash touching the globe, or evidence of epilation.
Data entry and analysis
Household data were summarised from paper survey forms as the number of children aged
1–9, the number of cases of TF in children aged 1–9, the number of individuals aged more than
14 and the number of TT cases in those over 14 in the household. These summary data were
entered into a Microsoft Access database by NEHP staff and subsequently analyzed in Stata
version 12.1 (StataCorp LP, College Station, USA). Confidence intervals were calculated using
theWilson score interval [12].
Casemanagement
All cases of TF along with their household contacts were treated with a single oral dose of azi-
thromycin as is NEHP policy. Pregnant women and infants under the age of 6 months were
instead offered tetracycline eye ointment. Individuals with TT were offered Trabut surgery free
of charge.
Ethical review
The study adhered to the tenants of the Declaration of Helsinki and was approved by The
Gambia’s Ministry of Health and SocialWelfare and by The Gambia Government/Medical
Research Council Unit, The Gambia Joint Ethics Committee.Written, informed consent was
obtained from all participants; in the case of minors, informed consent was obtained from the
parent or guardian.
Results
Trachoma prevalence
Over the course of the study period,we examined 19,205 children aged 1 to 9 years and 27,921
adults over the age of 14 years for trachoma. The prevalence of TF in children varied by zone in
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each of the three years (Table 1), ranging from 0 to 3.8% [95% Confidence Interval (CI), 2.5–
5.9]. In 2013, the final year of the survey, TF prevalence ranged from 0.2% (95% CI 0.1–0.9) to
3.2% (95% CI 2.3–4.4)
Prevalence of TT varied by year and by zone from 0 to 1.7% (95% 1.0–3.0) (Table 2). In the
final year of surveillance,TT prevalence ranged, by zone, from 0 to 0.6% (95% CI, 0.3–1.1).
Burden of trichiasis
The projected number of trichiasis cases in each zone was estimated by first calculating the
average TT prevalence in individuals aged over 14 and who were available to survey in each
zone over the course of the three-year study. The average prevalence per zone was then multi-
plied by 60% of the rural population in each zone [60% being the estimated proportion of the
Gambian population over 14 years of age and assuming that TT in young children is negligible
(no cases were observed among 19,205 children examined in the survey)] to determine an
approximate number of projected cases living in each zone (Table 3). Using this method, the
total number of projected cases across each of the nine zones was estimated to be 1,594.
In an effort to determine the number of trichiasis cases known to the NEHP, the trichiasis
registries held at seven of the eight major health facilities with dedicated eye health units were
Table 1. Prevalence of TF in children aged 1 to 9 years by surveillance zone in years 2011 to 2013.
2011 2012 2013
Zone n/N % (95%CI) n/N % (95%CI) n/N % (95%CI)
A 5/402 1.2 (0.5–2.9) 15/441 3.4 (2.1–5.5) 10/833 1.2 (0.7–2.2)
B 8/460 1.7 (0.9–3.4) 11/605 1.8 (1.0–3.2) 18/953 1.9 (1.2–3.0)
C 0/444 0 5/427 1.2 (0.5–2.7) 13/712 1.8 (1.1–3.1)
D 7/498 1.4 (0.7–2.9) 19/496 3.8 (2.5–5.9) 37/1163 3.2 (2.3–4.4)
E 0/412 0 3/459 0.7 (0.2–1.9) 2/829 0.2 (0.1–0.9)
F 11/556 2 (1.1–3.5) 17/679 2.5 (1.6–4.0) 7/1111 0.6 (0.3–1.3)
G 3/548 0.5 (0.2–1.6) 0/360 0 21/1019 2.1 (1.4–3.1)
H 4/763 0.5 (0.2–1.3) 7/1043 0.7 (0.3–1.4) 5/1111 0.5 (0.2–1.0)
I 1/602 0.2 (0.03–0.9) 20/629 3.2 (2.1–4.9) 6/1650 0.4 (0.2–0.8)
CI = Confidence Interval
doi:10.1371/journal.pntd.0004906.t001
Table 2. Prevalence of TT in adults greater than 14 years of age by surveillance zone in years 2011 to 2013.
Zone 2011 2012 2013
n/N % (95%CI) n/N % (95%CI) n/N % (95%CI)
A 6/603 1 (0.5–2.2) 3/649 0.5 (0.2–1.4) 3/1140 0.3 (0.1–0.8)
B 2/694 0.3 (0.1–1.0) 8/662 1.2 (0.6–2.4) 8/1425 0.6 (0.3–1.1)
C 3/664 0.5 (0.2–1.3) 5/663 0.8 (0.3–1.8) 10/964 1 (0.6–1.9)
D 12/686 1.7 (1.0–3.0) 3/699 0.4 (0.1–1.3) 2/1362 0.1 (0.04–0.5)
E 2/590 0.3 (0.1–1.2) 5/665 0.8 (0.3–1.7) 4/1329 0.3 (0.1–0.8)
F 2/837 0.2 (0.1–0.9) 5/993 0.5 (0.2–1.2) 7/1561 0.4 (0.2–0.9)
G 0/900 0 0/774 0 2/1982 0.1 (0.03–0.4)
H 0/771 0 0/805 0 0/1514 0
I 0/1043 0 1/1152 0.1 (0.02–0.5) 3/2794 0.1 (0.04–0.3)
CI = Confidence Interval
doi:10.1371/journal.pntd.0004906.t002
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examined. One registrywas unavailable. 570 TT cases were recorded in these registries.We
therefore estimate the total number of ‘unknown’ cases to be 1,024 (1,594 minus 570), which
represents 0.15% of the total rural population.
Discussion
The criteria for trachoma elimination, as outlined by theWHO, include less than 5% preva-
lence of TF in children aged 1–9 years and less than 0.1% prevalence unknown TT in the total
population [9]. Our results indicate that The Gambia has reached TF elimination in all surveil-
lance zones. The measured TF prevalence and the upper 95% confidence bound were under
5% in all zones at all time points with the exception of two zones in 2012, where the upper con-
fidence bounds were 5.5 and 5.0%. In 2013 however, these values were lower.
Re-introduction of ocularC. trachomatis infection after mass treatment has been docu-
mented in The Gambia, primarily through interaction with untreated communities in Senegal
[7, 13]. We also have recent antedotal evidence of migrants, some with active disease, leaving
Senegal and resettling in Gambian communities, potentially providing a means of re-infection.
However, it is not yet clear whether isolated re-infection events are enough to re-establish
transmission following local elimination [7]. Continued TF surveillancewill be important for
The Gambia and preliminary studies to evaluate the utility of serological tools to identify future
transmission events [14] have recently been conducted in the country.
We have estimated the number of ‘unknown’ trichiaisis cases in The Gambia at 1,024. This
represents roughly 0.15% of the total rural population or 1.5 cases per thousand and suggests
the elimination criteria for TTmay not yet have beenmet.While the projected prevalence of
unknown TT cases in Zones E through I are in-line with the elimination threshold, increased
numbers in Zones A to D, representing the western-most part regions of the country are above
the target currently set for elimination. Further resources directed toward active case hunting
may be needed to identify those TT cases that are not yet known to the NEHP.
The assessment of TT has received attention with the recognition that many countries,
including those that have made progress in reducing TF through trachoma control measures,
have substantial TT surgery backlogs [15, 16]. The rationale for the elimination threshold as
cases ‘unknown’ to the programme is that this best reflects this surgical backlog however, we
Table 3. Projected number of TT cases by surveillance zone.
Zone Total rural population Projected cases Known casesa Projected unknown cases Prevalence unknown casesb (%)
A 82,082 282 54 228 0.28
B 71,904 296 64 232 0.32
C 58,865 264 136 128 0.22
D 76,282 355 71 284 0.37
E 61,370 171 133 38 0.06
F 73,451 175 58 135c 0.08c
G 87,150 18
H 74,420 0 54 0d 0d
I 84,508 33
Total 670,032 1594 570 - -
a Cases documented at dedicated eye health clinics
b Prevalence unknown cases per total population
c Zones F and G served by one dedicated eye health clinic
d Zones H and I served by one dedicated eye health clinic
doi:10.1371/journal.pntd.0004906.t003
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found this number difficult to reconstruct from the available programme records. Dedicated
TT registries were found in all the eye health units we visited. All registers were hand-written
in bound notebooks. In several of the units, TT cases diagnosed in the health centre were
recorded in notebooks separate from those cases identified during community-screening exer-
cises, which made the total number of TT cases identified in a given year more cumbersome to
determine. A third registrywas often then used to record TT surgeries conducted.While a
number of units made a note of those individuals who were diagnosedwith TT but who then
refused surgery, many did not. Because of this and because different notebooks were used to
identify cases and record surgery details, there was no obvious way of determiningwhether all
cases had been offered appropriate treatment. Furthermore, the NEHP has continued to rec-
ommend epilation for minor TT (defined as 5 or fewer lashes rubbing the eyeball) and it is
unclear how many of those classified as TT, on the basis of epilation, were epilating on the
advice of the programme and therefore ‘known’ to the NEHP.
The Gambia is also lacking a robust means of documenting recurrent TT cases. Recurrent
cases are entered into the NEHP’s trichiasis registries along with all other TT cases identified.
While this means that recurrent TT is accounted for within the ‘known’ cases, it doesn’t enable
one to calculate the total percentage of TT cases that are recurrent. This is important as elimi-
nation criteria indicate that countries must report recurrence rates with a target of achieving
10% or less recurrence one year after surgery [9]. The Gambia would benefit from a central,
electronic TT registry that would enable data collection from across the country in a unified
manner and to ensure appropriate follow-up care of all cases identified. The use of electronic
data collection in the field has been shown to be feasible within the Global Trachoma Mapping
Project, which uses Android smartphones that transmit data to a high security server for clean-
ing and approval by the relevant Ministry of Health [17]. A similar system could conceivably
be developed to allow eye care units to report TT cases directly to the NEHP.
TT is diagnosed here according to the simplified classification of trachoma [11], this being
at least one lash in contact with the eyeball, or evidence of epilation. It is questionable how
accurately rural household surveys (of the kind needed to determine prevalence of TF) accu-
rately identify TT surgical need. Firstly, it is clear that cases of trichiasis can be found in urban
areas; a recent study in The Gambia found cases unknown to the programme within 200
metres of a functioning eye health unit [18]. Secondly, a survey based on households can only
find cases of TT that are present in the household and certain age groups are typically under-
represented in Gambian household surveys. This can be dealt with by standardising the esti-
mates against a rural population pyramid, but it is unclear that this would correct the estimates
appropriately if, for example, people with TTwere more likely to be found at home during tra-
choma surveys. A final issue concerns the relationships between TT as diagnosed here, tra-
choma and surgical need. The surgical procedures for TT, typically bilamellar tarsal rotation or
Trabut, are designed to correct entropion, the in-rolling of the lid margin that characteristically
follows contraction of trachomatous scarring of the eyelid [19]. However, not all trichiasis is
associated with entropion; neither lashes rubbing the eyeball nor epilation need be trachoma-
tous in origin [20]. What may be needed is a methodology for TT surveys that are designed to
better identify surgical backlog and that require TT be designated as trachomatous only when
trachomatous scarring is also present.
Our data, although limited for the reasons outlined above, estimate that rural Gambia has a
backlog of around 1,000 TT cases requiring surgery, against the elimination threshold allow-
ance of 1 per thousand of the population, or approximately 670 cases. The difference of 330 is a
relatively small number for a country where community ophthalmic nurses are trained to con-
duct Trabut surgery in health centres and in people’s homes and who, in the past three years,
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have conducted roughly 200 surgeries a year. With additional funding for enhanced case-find-
ing and TT surgery camps, it should be possible to reduce this number with relative ease.
Virtually no TTwas found in the most-eastern part of the country, encompassing the
Upper River Region. This is consistent with historical data of TF prevalence in this region. The
National Survey of Blindness carried out in 1986 documented a prevalence of active trachoma
[TF and/or trachomatous inflammation—intense (TI)] in children aged 0 to 14 years of 5% in
Upper River Region, half that of the prevalence found in the country as a whole [4]. By 1996,
this value had further dropped to 1.2% prevalence [5]. As the prevalence of TF in the rest of the
country has now reached these low levels, one may speculate that TT has the potential to disap-
pear from Gambian communities within the next two generations.
The estimates of TT cases remaining in the country are based on national census data from
2003, which is a further limitation of the study. The Gambia Statistics Department conducted
another nation-wide census in 2013 but the complete data-set from this survey has yet to be
released. However, the preliminary data that have beenmade public [21] suggest the bulk of
the population increase over the past decade has occurred in the urban areas, which are
excluded by theWHO guidelines for trachoma surveillance.We therefore do not anticipate the
projected numbers of TT cases will change dramatically once re-evaluated based on the 2013
census data.
Conclusions
Data collected during three years of rolling surveys indicate The Gambia has achieved the elim-
ination criteria for TF in children, representing a significant public health achievement. Further
efforts in identifying and a more robust system of documenting TT cases would help reduce
the number of unknown TT cases from the current figure of 0.15% total population to below
the 0.1% population elimination threshold.
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